Yale Cancer Center Study Explores New Path to Treat Advanced Triple-Negative Breast Cancer
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.
Source: yale.edu